Abstract
Excessive mucus production is a common and significant problem for several prominent human lung diseases such as asthma and chronic obstructive pulmonary disease (COPD). In these diseases, the mucus barrier poses a significant challenge to drug delivery, leading to increased healthcare cost and poor quality of life for patients. One method of overcoming structural and fluid resistance of mucus is by utilizing a targeted delivery method of magnetic nanoparticles (NPs) to diseased epithelial cells. However, previous experimental studies showed no mucus penetration using superparamagnetic iron oxide (Fe3O4) FeNPs. In our experiments we generated a field gradient that is an order of magnitude stronger than that in previously applied FeNP delivery systems. In our delivery system, FeNPs successfully penetrated the approximately 100 μm thick mucus layer of air-liquid interface cultured primary normal human tracheobronchial epithelial cells indicating the potential of magnetic nanoparticles for targeted drug delivery to the airway mucosal surface.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
